Raphael Reinbold

Raphael Reinbold has a diverse work experience starting in 2013 with a student internship at Pfizer. In 2015, they worked as a laboratory teaching assistant, laboratory demonstrator, and student research assistant at the University of Freiburg. In 2016, they completed a pharmacy placement at Public Pharmacy, followed by a diploma student role at the University of Oxford in 2017. In 2018, they were a DPhil student, postdoctoral researcher, and co-founder of a student-led conference called ChemBiOx at the University of Oxford. Additionally, that same year, they were a part of the BBSRC Grand Challenges for Technologies and Methods for Drug Discovery Skills School where they won a pitching competition. In 2022, they were an associate consultant at Princeton Biopartners before being hired as a senior scientist at OMass Therapeutics in 2023.

Raphael Reinbold has an education history that includes a State examination in Pharmacy from The University of Freiburg, which they completed between 2012 and 2016. Raphael then obtained a Diploma in Pharmacy from the same institution in 2017. In the same year, they attended the University of Oxford, where they enrolled in the GSK-Crick Chemical Biology Programme and completed a DPhil degree in 2021. Additionally, they obtained a Pharmacist Licence from Regierungspräsidium Stuttgart in January 2018.